Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,911,919
New position
Shares Held
55,571
first reported quarter
Ownership
0.033%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#147
of 421 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in ALKS
reported options exposure · as of Jun 30, 2026CallValue
$83,839
CallShares
1,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Atika Capital Management LLC holds $19,289,967 across 3 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (15.1% of the industry book) .
All Filings in ALKS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,911,919 | 55,571 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $83,839 | 1,600 | Call | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||